Assessing efficacy of stuttering treatments

Journal of Fluency Disorders

Volumn 26, Issue 4, 2001, Pages 311-333

  Thomas, Carys ^a   Howell, Peter ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Efficacy; Stuttering; Treatment

Indexed keywords

ARTICLE; CLINICAL PROTOCOL; CLINICAL RESEARCH; CLINICAL TRIAL; DATA ANALYSIS; EVALUATION; FOLLOW UP; HUMAN; META ANALYSIS; METHODOLOGY; PATIENT SELECTION; RELIABILITY; SAMPLE; SPEECH ARTICULATION; SPEECH THERAPY; STANDARD; STUTTERING; TRAINING; TREATMENT OUTCOME; VALIDATION PROCESS;

EID: 0035193401     PISSN: 0094730X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-730X(01)00103-6     Document Type: Article

References (114)

1. Stuttering: Overt and covert measurement of the speech of treated subjects
2. Regression to the mean in pre-treatment measures of stuttering
3. Treatment efficacy research in stuttering
4. Inferential statistics and treatment efficacy studies in communication disorders
5. A rapid method of eliminating stuttering by a regulated breathing approach
6. The critical issue in treatment efficacy is knowing why treatment was applied
7. On pluttering, skivvering and floggering: A commentary
8. The maintenance of fluency following intensive therapy
9. The modification of stuttering in a public school setting
10. Treatment efficacy: Stuttering
11. Evaluating childhood stuttering
12. Evaluating efficacy of treatment of stuttering: School-age children
13. Efficacy of intervention by speech-language pathologists: Stuttering
14. The chronic preservatives stuttering syndrome; incurable stuttering
15. Research needs in stuttering: Roadblocks and future directions
16. The reliability of observational data: I. Theories and methods for speech-language pathology
17. Current status of the stuttering treatment literature
18. Time interval analysis of interjudge and intrajudge agreement for stuttering event judgements
19. Time-out procedures for the modification of stuttering: Three case studies
20. Assessment strategies for stuttering
21. Treatment success for children who stutter: A critical review
22. A controlled clinical trial for stuttering in persons aged 9 to 14 years
23. Results of a traditional acupuncture intervention for stuttering
24. The preschool fluency development program: Assessment and treatment
25. Observer agreement on stuttering and disfluency
26. Evaluating treatment efficacy for adults: Assessment of stuttering disability
27. Early intervention with early childhood stuttering: A critical examination of the data
28. Evaluation of an intensive treatment program for stuttering in young children
29. Evaluation of the efficacy of a stutter modification program with particular reference to two new measures of secondary behaviours and control of stuttering
30. Epidemiology and genetics of stuttering
31. Research design for examining treatment efficacy in fluency disorders
32. Stuttering therapy for children
33. The development of phonology
34. What are we measuring?
35. Two- to six-year controlled-trial stuttering outcomes for children and adolescents
36. Facilitating transfer and maintenance of fluency in stuttering therapy
37. Methods of interval selection, presence of noise and their effects on detectability of repetitions and prolongations
38. Short- and long-term outcome in an intensive treatment program for adult stutterers
39. Relationship between covert and overt speech measures immediately before and immediately after stuttering treatment
40. Guidelines for documentation of treatment efficacy for young children who stutter
41. A comparison of covert and overt assessment procedures in stuttering therapy outcome evaluation
42. Stuttering
43. Stuttering treatment efficacy: Paradigm-dependent or -independent
44. Behavior therapy and stuttering: A review
45. Interclinic differences in stuttering-event counts
46. Self-measurement and evaluating stuttering treatment efficacy
47. Stuttering treatment outcome evaluation
48. Experimental investigation of the effects of frequency-altered auditory feedback on the speech of adults who stutter
49. Current progress and future plans for developing effective treatments: Comments and perspectives
50. Speech rates and turn-taking behaviors of children who stutter and their parents
51. Speaking rates, response time latencies, and interrupting behaviours of young stutterers, nonstutterers, and their mothers
52. Molecular self-analyses of stuttered speech via speech time expansion
53. An investigation of interclinic agreement in the identification of fluent and stuttered syllables
54. Evaluation of regulated breathing method with and without parental assistance in the treatment of child stutterers
55. Outcome predictors in the behavioural treatment of stuttering
56. Reporting observer agreement on stuttering event judgments: A survey and evaluation of current practice
57. Verbal versus tangible reward for children who stutter
58. Stuttering identification: Standard definition and moment of stuttering
59. Stuttering and speech naturalness
60. An experimental treatment with two preschool stuttering children
61. Case studies for evaluating statistical significance in group designs
62. Tempest is a t test? A reply to Finn and Gow
63. Fundamental methodological consideration in controlled clinical trials
64. The need for replication
65. Testing the hypothesis that treatments have negligible effects: Minimum-effect tests in the general linear model
66. Treatment efficacy research: A paradigm for investigating clinical practice and theory
67. Choosing a treatment procedure for early stuttering: Issues and future directions
68. Reliability of speech naturalness ratings of stuttered speech during treatment
69. A control/experimental trial of operant treatment for early stuttering
70. Speech outcomes of a prolonged-speech treatment for stuttering
71. Direct early intervention with stuttering
72. The stuttering intervention program
73. Continuity, fragmentation and tension: Hypothesis applied to evaluation and intervention with pre-school disfluent children
74. The psychology of treatment evaluation studies
75. An experimental treatment using verbal punishment with two preschool stutters
76. Intervention procedures for the disfluent child
77. Use of the Monterey programmed stuttering treatment in Great Britain
78. Operant procedures applied to stuttering treatment for children
79. Programmed stuttered therapy for children: Comparison of four established programs
80. Programmed stuttering treatment for children: Comparison of two establishment programs through transfer, maintenance, and follow-up
81. Time pressure variables in the verbal parent-child interaction patterns of fathers and mothers of stuttering, phonologically disordered and normal preschool children
82. Concluding remarks
83. Toward a comprehensive theory of stuttering: A commentary
84. Fluency changes in persons who stutter following a double blind trial of clomipramine and desipramine
85. Issues in the efficacy of treatment for fluency disorders
86. A pilot study of relations among specific measures obtained at intake and discharge in a program of prevention and early intervention for stuttering
87. Individual differences in phonological development: Ages one to three years
88. Evaluation and elimination of an avoidance response in a child who stutters: A case study
89. Epidemiological and other considerations in treatment efficacy research with preschool children who stutter
90. Disfluency characteristics of childhood stuttering
91. A longitudinal study of stuttering in children: A preliminary report
92. Predictive factors of persistence and recovery: Pathways of childhood stuttering
93. Clinical implications of situational variability in preschool children who stutter
94. Describing the consequences of disorders: Stuttering and the international classification of impairments, disabilities and handicaps
95. Critical dimensions in the choice and maintenance of successful treatments: Strength, integrity and effectiveness
96. Onset, prevalence, and recovery from stuttering
97. Observer agreement for marking moments of stuttering
98. Supplemental tests of statistical significance: Variation accounted for
99. Influence of nontreatment variables on treatment effectiveness for school-age children who stutter